A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

Overview of attention for article published in Trials, March 2022

Altmetric Badge

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 151 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 10,395 followers.

https://t.co/g12dUOdf3v

Reply Repost Favourite

RT @GR_SurvOnc: The MEDEA trial lead by our group is testing the impact of a supervised telehealth weight loss intervention on Cancer-Relat…

Reply Repost Favourite

RT @GR_SurvOnc: The MEDEA trial lead by our group is testing the impact of a supervised telehealth weight loss intervention on Cancer-Relat…

Reply Repost Favourite

The MEDEA trial lead by our group is testing the impact of a supervised telehealth weight loss intervention on Cancer-Related Fatigue among overweight or obese BC survivors. Recruitment is complete! https://t.co/sX2UMn3Ryf #gustaveroussy @ines_vazluis @di

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.